Showing 6361-6370 of 19367 results for "".
Where There are No Psychiatrists
https://reachmd.com/programs/clinicians-roundtable/where-there-are-no-psychiatrists/2979/Dr. Vikram Patel, professor of international mental health and the Wellcome Trust Senior Clinical Research Fellow at the London School of Hygiene and Tropical Medicine, discusses a community model in developing countries that empowers patients with mental illness to use collaborative psychosocial inEthical and Logistic Consequences of Closed Scientific Data
https://reachmd.com/programs/clinicians-roundtable/ethical-and-logistic-consequences-of-closed-scientific-data/2819/Dr. Andrew Vickers discusses the continuing trend of medical reseachers refusing to release raw data after publication. What impact does this make on delaying the advancement of science? Are doctors viewing these results as their personal property? Is there a danger that the public's perception willBridges To Excellence: Physician Office Link
https://reachmd.com/programs/clinicians-roundtable/bridges-to-excellence-physician-office-link/2806/Bridges to Excellence (BTE) is a national not-for-profit organization that designs and implements programs to recognize and reward physicians that deliver high quality care. In talking with BTE’s CEO, Francios de Brantes, host Dr. Bill Rutenberg learns about BTE’s methodology for measuring quality,Doctors:Unwilling Pawns in Healthcare Finance Game
https://reachmd.com/programs/revealing-retina/doctorsunwilling-pawns-in-healthcare-finance-game/2772/Dr. Roy Levit welcomes Dr. Michael Newton, Medical Ethicist and an Ophthalmologist specializing in corneal disease and transplantation. They will dicuss Dr. Newton's book, "Without Your Consent, The Hijacking of American Health Care". They will cover all of the outside influences from managed care tHope: A Complement to Cancer Treatment
https://reachmd.com/programs/clinicians-roundtable/hope-a-complement-to-cancer-treatment/2756/When it comes to cancer care, we know about chemotherapy, surgery, bone marrow transplants and even the coming of stem cell therapies. But should hope also be included as a treatment for these life threatening diseases? Dr. Edgar Staren, senior vice president for clinical affairs and chief medical oWhy We'll Never Cure Cancer?
https://reachmd.com/programs/clinicians-roundtable/why-well-never-cure-cancer/2389/What is keeping our society from moving forward in our ability to cure disease? How can what is learned in the lab be brought to the frontlines more quickly and efficiently? How can individual medical institutions work together to make a more profound difference in our healthcare system? Our GuestDiagnosing and Treating CF: What is new?
https://reachmd.com/programs/clinicians-roundtable/diagnosing-and-treating-cf-what-is-new/2099/Our guest Dr. Rick Moss discuses with host, Dr. Bill Rutenberg current modes of diagnosis, including the genetic basis of CF. This is followed by a discussion of current and future treatments for cystic fibrosis, including lung transplantation, stem cell and gene therapies.Challenges in Treating Polycystic Ovarian Syndrome
https://reachmd.com/programs/advances-in-womens-health/challenges-in-treating-polycystic-ovarian-syndrome/1879/Anovulation is a significant challenge for reproductive age women. The most common endocrinologic cause of this is PCOS. With the help of Dr. Sam Thatcher, pioneer in IVF technology and director of the Center for Applied Reproductive Science, we explore the exciting new possibilities and not-so-newGuiding a Department Through 9/11 in NYC
https://reachmd.com/programs/clinicians-roundtable/guiding-a-department-through-911-in-nyc/1431/Host Dr. Shira Johnson talks with Dr. Michael Sadler, section chief of the division of body CT at St. Vincent's Hospital Manhattan in downtown New York City, about his hospital's preparedness for 9/11 and its aftermath.Novel Therapies for HDL Cholesterol
https://reachmd.com/programs/clinicians-roundtable/novel-therapies-for-hdl-cholesterol/818/Will novel HDL cholesterol therapies reduce cardiovascular risk? Dr. Robert Rosenson will discuss the hope for CETP inhibitors and HDL mimetics to modify HDL cholesterol and coronary heart disease risk.